International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba , 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Graduate School of Pure and Applied Sciences, University of Tsukuba , 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8571, Japan.
J Med Chem. 2017 Feb 9;60(3):1018-1040. doi: 10.1021/acs.jmedchem.6b01418. Epub 2017 Jan 18.
Nalfurafine, a κ-selective opioid receptor agonist, unexpectedly showed a selective antagonist activity toward the orexin 1 receptor (OXR) (K = 250 nM). Modification of the 17-amino side chain of the opioid ligand to an arylsulfonyl group and the 6-furan acrylamide chain to 2-pyridyl acrylamide led to compound 71 with improvement of the antagonist activity (OXR, K = 1.36 nM; OXR, not active) without any detectable affinity for the opioid receptor. The dihydrosulfate salt of 71, freely soluble in water, attenuated the physical dependence of morphine. Furthermore, all of the active nalfurafine derivatives in this study had almost no activity for OXR, which led to high OXR selectivity. These results suggest that nalfurafine derivatives could be a useful series of lead compounds to develop highly selective OXR antagonists.
那拉呋定是一种 κ 型阿片受体选择性激动剂,出人意料地对食欲素 1 受体(orexin 1 receptor,OXR)表现出选择性拮抗活性(K i = 250 nM)。将阿片配体的 17 位氨基酸侧链修饰为芳基磺酰基,6-呋喃丙烯酰胺链修饰为 2-吡啶丙烯酰胺,得到化合物 71,其拮抗活性得到改善(OXR,K i = 1.36 nM;OXR,无活性),而对阿片受体几乎没有可检测的亲和力。71 的二氢硫酸盐盐在水中溶解度高,可减轻吗啡的身体依赖性。此外,本研究中所有具有活性的那拉呋定衍生物对 OXR 几乎没有活性,这导致了高 OXR 选择性。这些结果表明,那拉呋定衍生物可能是一组很有前途的先导化合物,可以开发出高选择性的 OXR 拮抗剂。